✦ LIBER ✦

423 Can Surgery Be Avoided in Patients with Breast Cancer Who Achieve a Complete Clinical Response to Neoadjuvant Chemotherapy?

✍ Scribed by A. Makris; S.P. Li; M. Pittam; D. Ravichandran

Book ID: 117662330
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 57 KB
Volume: 48
Category: Article
ISSN: 0959-8049
DOI: 10.1016/s0959-8049(12)70489-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The safety of breast-conserving surgery

The safety of breast-conserving surgery in patients who achieve a complete pathologic response after neoadjuvant chemotherapy

✍ Florentia Peintinger; W. Fraser Symmans; Ana M. Gonzalez-Angulo; Judy C. Boughey 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB 👁 2 views

3–48 The Safety of Breast-Conserving Sur

3–48 The Safety of Breast-Conserving Surgery in Patients Who Achieve a Complete Pathologic Response After Neoadjuvant Chemotherapy

✍ Newman, L.A. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 68 KB

A prognostic model to predict outcome of

A prognostic model to predict outcome of patients failing to achieve pathological complete response after anthracycline-containing neoadjuvant chemotherapy for breast cancer

✍ Sheng Chen; Can-Ming Chen; Ke-Da Yu; Wen-Tao Yang; Zhi-Ming Shao 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 272 KB

Metformin and Pathologic Complete Respon

Metformin and Pathologic Complete Responses to Neoadjuvant Chemotherapy in Diabetic Patients With Breast Cancer

✍ Jiralerspong, S.; Palla, S. L.; Giordano, S. H.; Meric-Bernstam, F.; Liedtke, C. 📂 Article 📅 2009 🏛 American Society of Clinical Oncology 🌐 English ⚖ 115 KB

Metformin and Pathologic Complete Respon

Metformin and Pathologic Complete Responses to Neoadjuvant Chemotherapy in Diabetic Patients With Breast Cancer

✍ Jiralerspong, S.; Palla, S. L.; Giordano, S. H.; Meric-Bernstam, F.; Liedtke, C. 📂 Article 📅 2009 🏛 American Society of Clinical Oncology 🌐 English ⚖ 115 KB

## Purpose Population studies have suggested that metformin use in diabetic patients decreases cancer incidence and mortality. Metformin inhibits the growth of cancer cells in vitro and tumors in vivo. However, there is little clinical data to support this. Our purpose was to determine whether met

Outcomes in Patients With Clinical Stage

Outcomes in Patients With Clinical Stage III NSGCT Who Achieve Complete Clinical Response to Chemotherapy at Extraretroperitoneal Disease Site

✍ Timothy A. Masterson; Brett S. Carver; Bobby Shayegan; Darren R. Feldman; Robert 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 224 KB